Edited and reviewed by: Georgina Louise Jones, Leeds Beckett University, United Kingdom
This article was submitted to Maternal Health, a section of the journal Frontiers in Global Women's Health
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
香京julia种子在线播放
The SARS-CoV-2 virus that causes COVID-19 emerged in Wuhan, China, in November 2019. Cases were officially recognized in December 2019 and, by February 2020, the virus had spread internationally. On 11 March 2020, the World Health Organization declared the outbreak a global pandemic.
COVID-19 has had a profoundly negative impact globally on physical and mental health, health care, and social functioning, across all age groups and medical conditions, although women may have been disproportionately affected.
What seemed initially to require a brief period of global lockdown, with at worst a return to the delivery of normal health services by autumn 2020, has resulted worldwide in ongoing restrictions in social activity and travel despite successful international vaccination programmes and infectious disease tracking and tracing.
Our Research Topic was launched on 5 May 2020 with a planned close on 8 September 2020, which was extended until 31 December 2020 due to a high number of submissions. These reflect people's experiences and associated health outcomes during the first and second waves of COVID-19.
Our Research Topic attracted keen interest from potential contributors worldwide. We accepted 39 manuscripts from the Americas (
By September 2020, a rapid narrative review by
In their review,
When the pandemic first emerged, there was concern that pregnant women would be more susceptible to SARS-CoV-2 infection, as they had been with other coronavirus outbreaks, i.e., Severe Acute Respiratory Syndrome (SARS) and Middle East Respiratory Syndrome (MERS). Although by February 2021, this was no longer thought to be the case, it was clear that when infected, pregnant women were more likely to develop severe disease and pregnancy complications (particularly preterm birth), especially in the third trimester. The
While COVID-19 is clearly associated with more pregnancy complications, it is also clear that the pandemic itself has disrupted maternity services for all pregnant women, whether infected or not. This was highlighted by
Our Research Topic attracted a broad range of manuscripts from researchers across the globe, with more than half of studies focussed on women's health in general (rather than pregnancy/postpartum specifically), and as much interest in the indirect consequences of the pandemic as in the direct implications of SARS-CoV-2 infection itself. This represents a broad collection of global perspectives. The topic dovetails with two others. First, is the “Vaccination in pregnancy” topic that loses for submission of abstracts on 20 January 2022, and to full manuscripts on 31 January 2022 (
SK and LM outlined the general structure of the editorial. LM wrote the initial draft. All authors contributed to the article and approved the submitted version.
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
1